⭐ FeaturedNSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
CORONA Remedies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
CORONA Remedies Limited reported a 21.9% year-on-year revenue growth in Q1 FY27, surpassing its stated growth guidance of 15%. The company's India business delivered an impressive 22.7% year-on-year revenue growth, significantly outperforming the Indian Pharmaceutical Market, which grew by 11.6% during the same period.
⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026
IOL Chemicals & Pharmaceuticals Ltd
Press Release- Financial Results for the quarter ended 30th June 2026
IOL Chemicals & Pharmaceuticals Ltd reported its Q1 FY27 results, with revenue from operations increasing 37.1% YoY to ₹756.3 Cr, EBITDA rising 60.7% YoY to ₹111.7 Cr, and PAT increasing 89.9% YoY to ₹64.5 Cr. The company's Pharmaceuticals business saw a 43% YoY revenue growth and 72% YoY EBIT growth, driven by improved capacity utilisation, favourable product mix, and operational efficiencies.
⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026
NINtec Systems Ltd
Press Release - Declaration of Financial results for quarter ended 30th June, 2026
NINtec Systems Ltd has announced its unaudited consolidated financial results for the quarter ended 30 June 2026, showing revenue growth of 18.1% and operating profit growth of 40.9%, with employee cost decreasing by 4.8%. The company's operating margin expanded by 420 basis points to 25.9%.
⭐ FeaturedBSEResult▲ PositiveResults10 Aug 2026
Promact Plastics Ltd
The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We are enclosing herewith copy of the ....
Promact Plastics Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 1645.04 crore from continuing operations, compared to a loss of Rs. 14.53 crore in the same quarter last year.
⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026
Fusion Finance Ltd
Press release on financial results for the quarter ended June 30, 2026
Fusion Finance Ltd reported strong Q1 FY27 performance with PBT rising 67% QoQ to INR 62 crore, driven by improvement in profitability, asset quality, and growth.
⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026
SPR Auto Technologies Ltd
Transcripts
SPR Auto Technologies Ltd has announced its Q1 FY27 earnings, with a 51% year-on-year growth in consolidated total income and a 27% year-on-year growth in consolidated EBITDA. The company has delivered a strong financial performance despite challenging industry conditions, with a 7% year-on-year growth in consolidated profit before tax and a 9% year-on-year growth in profit after tax.
⭐ FeaturedNSEPress Release▲ PositiveOrder Win10 Aug 2026
Jupiter Wagons Limited
Press Release
Jupiter Wagons Limited has secured two significant orders worth over Rs. 211 Crore from JSW Port Logistics Private Limited and Orissa Alloy Steel Private Limited, reinforcing its position as a trusted partner in India's evolving freight logistics sector.
⭐ FeaturedBSEAGM/EGM▲ PositiveFundraise10 Aug 2026
Bal Pharma Ltd
Outcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 , 2026
Bal Pharma Ltd has announced the outcome of its postal ballot, where the shareholders approved the issue of 10,00,000 Warrants to the Promoter on a preferential basis. The voting results showed 99.96% of the total votes received in favor of the resolution, with only 0.04% against it.
⭐ FeaturedBSECorp Action▲ PositiveDividend10 Aug 2026
Eco Recycling Ltd
The Board has Approved the Dividend of Rs. 1.00 (10% of Face Value) on each equity share. we have enclosed the outcome of board Meeting dated August 10, 2026
The Board of Eco Recycling Ltd has approved the dividend of Rs. 1.00 (10% of Face Value) on each equity share. The dividend will be paid on September 11, 2026, and the record date is August 22, 2026.
⭐ FeaturedBSECompany Update▲ PositiveResults10 Aug 2026
Shilpa Medicare Ltd
Q1FY27 earnings conference call transcript
Shilpa Medicare Ltd has announced its Q1FY27 earnings conference call transcript, highlighting its strong performance and future growth prospects. The company has reduced its net debt-to-EBITDA ratio to 1.3x and achieved a double-digit ROCE. It has also made significant investments in biologics, CDMO, and novel drug delivery, with plans to monetize these assets in the future.
⭐ FeaturedBSEAGM/EGM▲ PositiveMgmt Change10 Aug 2026
BPL Ltd
Scrutiniser Report for Postal Ballot
BPL Ltd has announced the scrutinizer report for its postal ballot, with 99.96% of shareholders voting in favor of re-appointing Mr. CK Sabareeshan as an independent director for a further period of 5 years. The resolutions stand passed with the requisite majority.
⭐ FeaturedNSEInvestor Presentation▲ PositiveResults10 Aug 2026
Gretex Corporate Services Limited
Investor Presentation
Gretex Corporate Services Limited has submitted a revised investor presentation for the Q1-FY27 earnings call, highlighting strong revenue and profitability growth, with consolidated revenue increasing by 70.5% YoY and PAT margins expanding by 2959 bps YoY.
⭐ FeaturedNSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
Mayur Uniquoters Ltd
Analysts/Institutional Investor Meet/Con. Call Updates
Mayur Uniquoters Ltd has informed the Exchange about the transcript of Earnings Conference Call held on August 06, 2026. The company has achieved revenue from operations on a standalone basis of INR247.03 crores, PBT of INR77.79 crores, and PAT of INR58.95 crores. The revenue from operations on a consolidated basis is INR269.23 crores, PBT of INR74.12 crores, and PAT of INR56.12 crores. The company has received OEM supply orders from the U.S.A. and has plans to expand its business in the next 2-3 years.
⭐ FeaturedBSECorp. Action▲ PositiveDividend10 Aug 2026
Upsurge Investment & Finance Ltd
The Board in its meeting held on 10.08.2026 has declared interim dividend @ 5% i.e. Re. 0.50 per shares for the financial year 2026-2027
Upsurge Investment & Finance Ltd declared an interim dividend of 5% i.e. Re. 0.50 per equity share for the financial year 2026-2027. The record date for determining the entitlement of shareholders for the payment of the interim dividend is Friday, 21st August, 2026.
⭐ FeaturedNSEGeneral Updates▲ PositiveExpansion10 Aug 2026
K.P.R. Mill Limited
General Updates
K.P.R. Mill Limited has announced a comprehensive capacity expansion and modernization plan across its textile value chain, with a total investment of Rs. 1,225 Crores and expected turnover of Rs. 2,000 Crores.
⭐ FeaturedBSECompany Update▲ PositiveOrder Win10 Aug 2026
Jash Engineering Ltd
Corporate Announcement
Jash Engineering Ltd has commissioned a major expansion in its foundry, increasing casting production by 50%, and expanded its cast gate & cast valve manufacturing capacity by 30%. The company has also received necessary approvals for its proposed Saudi plant and reported a consolidated order book position of Rs. 932 Cr as of 1st August 2026.
⭐ FeaturedNSEInvestor Presentation▲ PositiveResults10 Aug 2026
Power Mech Projects Limited
Investor Presentation
Power Mech Projects Limited has announced its Q1 FY 2027 earnings, with revenue growing 26% YoY to INR 1,624 Cr, EBITDA at INR 176 Cr, and order inflows of INR 1,864 Cr. The company has an order backlog of INR 55,398 Cr and is focused on disciplined execution, improving profitability, and executing the order pipeline across core and emerging businesses.
⭐ FeaturedNSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
Sanofi India Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Sanofi India Limited has announced its unaudited financial results for the quarter and half year ended 30th June 2026, with a strong momentum in the diabetes business, driven by double-digit growth in the domestic market, powered by innovative portfolio, Toujeo and Soliqua. The company has also reported a 2% growth in quarter two over last year's quarter two, based on the continued ROI from partnership with Emcure and Cipla.